PATENT CLAIM ANALYSIS

Application Number: 15950889
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["435", "006100"]

Abstract:
Disclosed are methods for detecting the presence of a carcinoma or an increased likelihood that a carcinoma is present in a subject. More particularly, the present invention discloses methods for diagnosis, screening, treatment and monitoring of carcinomas associated with aberrant DNA methylation of the MED15 promoter region.

Claim (Index 60):
A composition according to  claim 57 , wherein the head and neck squamous cell carcinoma (HNSCC) is an oral squamous cell carcinoma (OSCC).

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.33333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10955340', '12231337', '13634321', '15032638', '13224024']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6468708259322712
- 35 USC 102 Novelty (BERT): 0.5179138269530993
- Combined Prediction Score: 0.633975126034354
- Mean Citation Score: 299.196558
- Max Citation Score: 312.9905
- Similarity Product: 212.02509801781173

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test